Deals

Data Byte

Data Graphics


<div class="articleContainer"></div>
<div class="articleWrapper">
<div class="articleContent">
<h1 class="text title" doc-editable="text" data-component-id="doc-1ef7l320d0">Data Byte: NK cell therapies draw slew of partnerships in 2020</h1><h2 class="title-bottom" doc-editable="title" data-component-id="doc-1ef7l34r60"></h2><div class="byline ng-tns-c17-4 ng-star-inserted" data-component-id="doc-1ef7l3fol0">
    <span class="ng-tns-c17-4" doc-editable="text">By Amanda Micklus, Senior Biopharma Analyst</span>
</div><div class="date" data-component-id="doc-1ef7l3l440">
  <span class="byline" doc-editable="text"></span>
</div></div></div>


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

Sanofi

Kiadis Pharma N.V.

Biopharma companies have signed at least 15 partnerships year to date focused on NK cell therapies, the modality that led to Kiadis&#x2019;&#xa0;&#x20ac;30...

Data Byte: NK cell therapies draw slew of partnerships in 2020

Biopharma companies have signed at least 15 partnerships year to date focused on NK cell therapies, the modality that led to Kiadis’ €308 million ($358 million) acquisition by

!function(e,i,n,s){var t="InfogramEmbeds",d=e.getElementsByTagName("script")[0];if(window[t]&&window[t].initialized)window[t].process&&window[t].process();else if(!e.getElementById(n)){var o=e.createElement("script");o.async=1,o.id=n,o.src="https://e.infogram.com/js/dist/embed-loader-min.js",d.parentNode.insertBefore(o,d)}}(document,0,"infogram-async");